Helen of Troy Limited
Helen of Troy Limited is a global consumer products enterprise that markets a diverse array of goods across the United States, Canada, Europe, the Middle East, Africa, the Asia Pacific region, and Latin America. The company's operations are structured into three primary divisions: Home & Outdoor, Health & Wellness,…
1D
-1.8%
1W
+9.4%
1M
+6.5%
6M
+53.7%
YTD
+36.4%
1Y
+45.9%
2Y
-57.2%
5Y
-87.2%
10Y
-65.0%
Next earnings date
14/01/2027 (in 89 days)
Volatility around earnings
~134% stronger price swings than usual
PRICE TARGET LOW
US$26.00
CONSENSUS
US$27.00
MEDIAN
US$27.00
PRICE TARGET HIGH
US$28.00
0
STRONG BUY
3
BUY
8
HOLD
0
SELL
0
STRONG SELL
11
TOTAL · Hold
As of: 09/10/2026
P/E
-6.66
P/B
0.79
EV/EBITDA
17.46
RETURN ON EQUITY
0.5%
NET MARGIN
1.1%
DEBT/EQUITY
0.85
DIVIDEND YIELD
0.0%
AS OF
31/08/2026
FREE FLOAT
97.5%
FLOAT SHARES
22,810,724
AVG. DAILY VOLUME (30D)
521,421
Grass Brian
Uzzell George Scott
Otero Elena
CASE THURMAN K
Berry Krista
Helen of Troy Limited is a company in the Consumer Defensive sector, Household & Personal Products industry, headquartered in United States.
The CEO is George Scott Uzzell, the company employs around 1,854 people.
The IPO was on 08/07/1976; the stock trades on NASDAQ under the ticker HELE.
11 analysts rate the stock, the consensus is Hold (as of 09/10/2026).
The average price target is US$27.00, ranging from US$26.00 to US$28.00, with a median of US$27.00.
This is an external assessment, not a statement by Market Jury.
The next earnings date is 14/01/2027.
Around past earnings, price swings were roughly 134% stronger than usual.
No, Helen of Troy currently does not pay a dividend.
Comparable stocks include Procter & Gamble Company, Colgate-Palmolive Company, Estée Lauder Companies, Kenvue, Kimberly-Clark, Church & Dwight, Clorox Company and Coty.
Clicking "Analyze stock" lets five strategies assess Helen of Troy against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.